Form 4: Centessa CEO Mario Accardi Reports Share Withholding

Centessa Pharmaceuticals CEO Mario Accardi reported the withholding of 604 ordinary shares to satisfy tax obligations related to RSU vesting.

Summary

• Mario Accardi, CEO of Centessa Pharmaceuticals, executed a transaction on May 1, 2026.
• The transaction involved the withholding of 604 ordinary shares by the company.
• The shares were withheld at a price of $39.42 per share.
• The purpose of the withholding was to cover tax obligations associated with the vesting of restricted share units (RSUs).
• Following this transaction, the reporting person maintains a beneficial ownership of 243,282 ordinary shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a mandatory tax-related transaction rather than a strategic shift or market-driven trade.

Positives

• The transaction is a routine administrative action related to tax withholding upon RSU vesting, rather than a discretionary open-market sale.

Negatives

• The transaction results in a minor reduction in the direct shareholding of the CEO.

Risks

• None identified; this is a standard regulatory disclosure for executive compensation tax compliance.

Future Outlook

Not applicable; this is a retrospective disclosure of a completed transaction.

Industry Context

StockSavvy.ai notes that routine tax withholding transactions for executives are standard practice in the biotechnology sector and do not typically signal changes in management sentiment or company outlook.

Comparison to Industry Standards

• The transaction follows standard corporate governance practices for equity-based compensation in publicly traded pharmaceutical companies.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a standard tax-related administrative process.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Centessa Pharmaceuticals, CNTA, Form 4, Insider Trading, Executive Compensation, Tax Withholding